BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 19139189)

  • 1. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
    Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
    Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
    Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
    Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
    Pinder M; Sutherland CJ; Sisay-Joof F; Ismaili J; McCall MB; Ord R; Hallett R; Holder AA; Milligan P
    Infect Immun; 2006 May; 74(5):2887-93. PubMed ID: 16622227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria.
    Courtin D; Oesterholt M; Huismans H; Kusi K; Milet J; Badaut C; Gaye O; Roeffen W; Remarque EJ; Sauerwein R; Garcia A; Luty AJ
    PLoS One; 2009 Oct; 4(10):e7590. PubMed ID: 19859562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria.
    Metzger WG; Okenu DM; Cavanagh DR; Robinson JV; Bojang KA; Weiss HA; McBride JS; Greenwood BM; Conway DJ
    Parasite Immunol; 2003 Jun; 25(6):307-12. PubMed ID: 14507328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.
    Reiling L; Richards JS; Fowkes FJ; Wilson DW; Chokejindachai W; Barry AE; Tham WH; Stubbs J; Langer C; Donelson J; Michon P; Tavul L; Crabb BS; Siba PM; Cowman AF; Mueller I; Beeson JG
    PLoS One; 2012; 7(9):e45253. PubMed ID: 23028883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.
    Dobaño C; Quelhas D; Quintó L; Puyol L; Serra-Casas E; Mayor A; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Puniya SK; Singh B; Gupta P; Bhattacharya A; Chauhan VS; Aponte JJ; Chitnis CE; Alonso PL; Menéndez C
    Clin Vaccine Immunol; 2012 Feb; 19(2):157-66. PubMed ID: 22169088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.
    Stanisic DI; Fowkes FJ; Koinari M; Javati S; Lin E; Kiniboro B; Richards JS; Robinson LJ; Schofield L; Kazura JW; King CL; Zimmerman P; Felger I; Siba PM; Mueller I; Beeson JG
    Infect Immun; 2015 Feb; 83(2):646-60. PubMed ID: 25422270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of antigen-specific immunoglobulin G subclasses in response to conserved and polymorphic Plasmodium falciparum antigens in an in vitro model.
    Garraud O; Perraut R; Diouf A; Nambei WS; Tall A; Spiegel A; Longacre S; Kaslow DC; Jouin H; Mattei D; Engler GM; Nutman TB; Riley EM; Mercereau-Puijalon O
    Infect Immun; 2002 Jun; 70(6):2820-7. PubMed ID: 12010968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.
    Weaver R; Reiling L; Feng G; Drew DR; Mueller I; Siba PM; Tsuboi T; Richards JS; Fowkes FJI; Beeson JG
    Sci Rep; 2016 Sep; 6():33094. PubMed ID: 27604417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.
    Taylor RR; Allen SJ; Greenwood BM; Riley EM
    Am J Trop Med Hyg; 1998 Apr; 58(4):406-13. PubMed ID: 9574783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.
    O'Flaherty K; Ataíde R; Zaloumis SG; Ashley EA; Powell R; Feng G; Reiling L; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJI
    J Infect Dis; 2019 Aug; 220(7):1178-1187. PubMed ID: 31075171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02
    Berry AA; Gottlieb ER; Kouriba B; Diarra I; Thera MA; Dutta S; Coulibaly D; Ouattara A; Niangaly A; Kone AK; Traore K; Tolo Y; Mishcherkin V; Soisson L; Diggs CL; Blackwelder WC; Laurens MB; Sztein MB; Doumbo OK; Plowe CV; Lyke KE
    Malar J; 2019 Jan; 18(1):13. PubMed ID: 30658710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of antibody responses to selected Plasmodium falciparum merozoite surface antigens in mild and cerebral malaria and associations with clinical outcomes.
    Mbengue B; Fall MM; Varela ML; Loucoubar C; Joos C; Fall B; Niang MS; Niang B; Mbow M; Dieye A; Perraut R
    Clin Exp Immunol; 2019 Apr; 196(1):86-96. PubMed ID: 30580455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of crude Plasmodium falciparum antigens for comparison of antibody responses in patients with mild malaria vs. cerebral malaria.
    Mbengue B; Niang B; Diatta B; Tall A; Garraud O; Perraut R; Dieye A
    Iran J Immunol; 2010 Sep; 7(3):150-61. PubMed ID: 20876986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.
    Soe S; Theisen M; Roussilhon C; Aye KS; Druilhe P
    Infect Immun; 2004 Jan; 72(1):247-52. PubMed ID: 14688102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania.
    Segeja MD; Mmbando BP; Seth MD; Lusingu JP; Lemnge MM
    BMC Infect Dis; 2010 Mar; 10():55. PubMed ID: 20205959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.